Medication Assisted Treatment (MAT)/Medication for Opioid Use Disorder (MOUD) Prescriber Pilot Program – Extended
During this time of COVID -19 crisis we need continued awareness that the other public health crisis, opioid use disorder, has not gone away and may potentially get worse. Because of this, the Federal Government has issued new guidelines allowing for the prescribing of opioid use disorder medication without a face-to face-patient visit.
Overdose Lifeline has been able to secure additional resources to provide reimbursement for physicians, nurse practitioners and physicians assistants willing to become eligible to prescribe medication assisted treatment (MAT) / medication for opioid use disorder (MOUD).
Tools are now available to provide an evidence-based, medication to treat opioid use disorder.
Become a MAT/MOUD Waiver Prescriber
MAT/MOUD is the use of medications in combination with counseling and behavioral therapies. Research has shown that removing an individual’s drug use through detoxification without the use of medications has a high failure rate of >90% within 3 months. A common misconception associated with MAT/MOUD is that it substitutes one drug for another.
Rather, these medications relieve the withdrawal symptoms and psychological cravings that cause chemical imbalances in the body. MAT/MOUD programs provide a safe and controlled level of medication to overcome the use of an abused opioid. Research has shown that when provided at the proper dose, medications used in MAT/MOUD have no adverse effects on a person’s intelligence, mental capability, physical functioning or employability.
Overdose Lifeline (ODL) is a proud member of the Voices for Non-Opioid Choices Coalition based out of Washington D.C. Being a member of the Voices Coalition aligns with our mission to carry the message of HOPE to individuals, families, and communities affected by the disease of addiction.
Opioid use disorder (OUD) frequently begins with a legitimately prescribed pain medication. ODL is not advocating to remove all pain medication we are merely advocating for the opportunity to receive alternatives to a prescription.
Recently, a bipartisan group of members of Congress in both the House and the Senate have introduced the Non-Opioids Prevent Addiction in the Nation Act (“NOPAIN Act”). This important piece of legislation is designed to increase the utilization of non-opioid acute pain management approaches pain by updating outdated reimbursement policies. Currently, limited reimbursement for non-opioid treatments and therapies has limited patient and provider access to these approaches. To address this, the NOPAIN Act would provide better reimbursement for such approaches and give patients and providers a choice in how they manage pain with options that are safe, effective, and non-addictive.
Happy New Year Greetings from Overdose Lifeline!
As we look toward a new year and a new decade we give thanks to the friends and supporters of Overdose Lifeline (ODL), our Board of Directors and Staff. Each in their own way contributing to the fulfillment of our mission, “to carry the message of HOPE to individuals, families, and communities affected by the disease of addiction.”
Here are the highlights of Overdose Lifeline's accomplishments in meeting our mission in 2019.
Accomplishments in Education